Get started
Author

Swathi Swaroopa Borra

Observed names: Borra, Swathi Swaroopa, Swathi Swaroopa Bora
ORCID: 0000-0003-1139-4124
Observed ORCID: 0000-0003-1139-4124
OpenAlex ID: A5080899430
A study on drug–drug interactions through prescription analysis in a South Indian teaching hospital
2013 · Vijay Kulkarni, Swathi Swaroopa Bora, et al. · Therapeutic Advances in Drug Safety · 43
Genetic polymorphism of organic cation transporter 2 (OCT2) and its effects on the pharmacokinetics and pharmacodynamics of Metformin: a narrative review
2023 · Swathi Swaroopa Borra, Niva Rose Jane, et al. · Egyptian Journal of Medical Human Genetics · 11
PDF
Enhancing the empiric antibiotic selection by introducing an antibiogram toolkit in a tertiary care hospital in Southern India – A prospective study
2021 · Sadagoban G. Krishnamoorthy, Vyshak Raj, et al. · Journal of Clinical Pharmacy and Therapeutics · 6
PDF
Development and validation of A-SOAP notes: Assessment of efficiency in documenting patient therapeutic records
2021 · Pooja Sudarsan, Aishwarya Gowda Murulya Balakrishna, et al. · Journal of Applied Pharmaceutical Science · 5
A Comprehensive Review on Efficacy and Adverse Events Associated With Different Covid-19 Vaccines
2022 · Swathi Swaroopa Borra, Narenthiran C K, et al. · Jordan Journal of Pharmaceutical Sciences · 4
PDF
A cumulative review on the utilisation of drug information services provided in India
2021 · G K Sadagoban, Aiswarya Baiju, et al. · Journal of Pharmaceutical Health Services Research · 4
ICT-enabled teaching and learning modalities followed in pharmacy education during COVID-19 in India
2022 · Sadagoban Gopal Krishnamoorthy, Grace Thomas, et al. · Journal of Applied Pharmaceutical Science · 3
PDF
Comprehending healthcare professionals’ perspectives and expectations on drug information services at point-of-care: an online survey
2022 · Sadagoban Gopal Krishnamoorthy, Samantha Sanjeev, et al. · Drugs & Therapy Perspectives · 3
Pharmacogenomics in oncology: mutation-targeted therapy and biomarker integration in non-small cell lung cancer
2026 · Mohammad Noor Shaik, Goutham Yerrakula, et al. · Clinical & Translational Oncology · 2
Cost-effectiveness analysis of Dapagliflozin versus Canagliflozin in treatment of type 2 diabetes mellitus
2022 · Sadagoban Gopal Krishnamoorthy, Jemi Rachel Shaji, et al. · Journal of Applied Pharmaceutical Science · 1
PDF
A systematic review of preclinical animal studies on fenofibrate’s potential role in type 1 diabetic micro-vascular complications
2023 · Varghese, Resia, Krishnamoorthy, Sadagoban Gopal, et al. · Figshare
A systematic review of preclinical animal studies on fenofibrate’s potential role in type 1 diabetic micro-vascular complications
2023 · Varghese, Resia, Krishnamoorthy, Sadagoban Gopal, et al. · Figshare
Efficacy of mindfulness meditation in psychological distress exacerbated tinea cruris: A case report
2022 · Swathi Swaroopa Borra, Jemi Rachel Shaji, et al. · Journal of Applied Pharmaceutical Science
PDF
Development and validation of methodology to study the genetic polymorphism of organic cation transporter 1 (OCT1) - rs622342: A Prospective open-label study
2022 · Swathi Swaroopa Borra, Diya Choorapra, et al. · Journal of medical pharmaceutical and allied sciences
A systematic review of preclinical animal studies on fenofibrate’s potential role in type 1 diabetic micro-vascular complications
2022 · Resia Varghese, Sadagoban Gopal Krishnamoorthy, et al. · Brazilian Journal of Pharmaceutical Sciences
PDF
Mucormycosis in COVID-19: modifiable risk factors and its mitigation in India
2021 · Shaji, Sherin Mary, Krishnamoorthy, Sadagoban Gopal, et al. · Italian Journal of Mycology
PDF
Prevalence of OCT1 (rs628031) genetic polymorphism in south Indian population
2021 · Swathi Swaroopa Borra, Bhavya Chebrolu, et al. · Journal of Applied Pharmaceutical Science
Works count: 17
Citation count: 82
H-index: 4
I10-index: 2
Year
Topic
Type